方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| UHDRS：统一亨廷顿病评定量表× | MDS-UPDRS：运动障碍协会（Movement Disorder Society）赞助的帕金森病统一评分量表× | |
|---|---|---|
| 领域 | 神经病学 | 神经病学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1996 | 2008 |
| 提出者≠ | Huntington Study Group | Christopher G. Goetz and Movement Disorder Society |
| 类型≠ | Clinician-rated and performance-based | Clinician-rated |
| 开创性文献≠ | Huntington Study Group (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136-142. link ↗ | Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗ |
| 别名≠ | UHDRS, Huntington's Rating Scale | UPDRS |
| 相关≠ | 4 | 5 |
| 摘要≠ | The Unified Huntington's Disease Rating Scale (UHDRS) is the comprehensive, multidomain assessment instrument for Huntington's disease, a neurodegenerative disorder caused by expanded CAG trinucleotide repeats. Developed by the Huntington Study Group in 1996, the UHDRS measures motor, cognitive, functional, and psychiatric manifestations of disease. The UHDRS is the gold-standard outcome measure in Huntington's disease clinical trials and longitudinal natural history studies. | The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice. |
| ScholarGate数据集 ↗ |
|
|